IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q3 2025 Holdings

Filed 2025-11-13 | 2 holdings | $274.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Maze Therapeutics, Inc.(MAZE)COM578784100$157.5M6,073,95857.5%
Tango Therapeutics, Inc.(TNGX)COM87583X109$116.5M13,863,97542.5%